Table 1 Baseline characteristics between the two groups
Variables | Survivors(n = 1786) | Non-survivors(n = 473) | Total(n = 2259) | p-value |
|---|---|---|---|---|
Age | 46.0 [37.0;55.0] | 52.0 [43.0;65.0] | 48.0 [38.0;56.5] | < 0.001 |
Sex | 0.495 | |||
Male | 1469 (82.3%) | 382 (80.8%) | 1851 (81.9%) | |
TBSA | 24.0 [14.0;37.0] | 65.0 [42.0;85.0] | 29.0 [17.0;48.0] | < 0.001 |
Type | < 0.001 | |||
FB | 1228 (68.8%) | 421 (89.0%) | 1649 (73.0%) | |
EB | 318 (17.8%) | 9 (1.9%) | 327 (14.5%) | |
SB | 156 (8.7%) | 30 (6.3%) | 186 (8.2%) | |
CoB | 50 (2.8%) | 10 (2.1%) | 60 (2.7%) | |
ChB | 34 (1.9%) | 3 (0.6%) | 37 (1.6%) | |
Inhalation | 812 (45.5%) | 370 (78.2%) | 1182 (52.3%) | < 0.001 |
APACHE IV | 33.0 [24.0;45.0] | 62.0 [49.0;76.0] | 38.0 [26.0;53.0] | < 0.001 |
Hangang | 122.0 [113.0;132.0] | 161.0 [149.0;177.0] | 127.0 [115.0;144.0] | < 0.001 |
ABSI | 7.0 [6.0; 9.0] | 12.0 [10.0;14.0] | 8.0 [6.0;10.0] | < 0.001 |
LOS | 15.0 [6.0;35.0] | 12.0 [7.0;22.0] | 14.0 [6.0;32.0] | 0.001 |
Laboratory | ||||
WBC(× 103/uL) | 17.3 [13.0;22.7] | 29.2 [20.6;37.4] | 18.7 [13.7;26.0] | < 0.001 |
Platelet(× 103/uL) | 230.5 [186.0;280.0] | 193.0 [134.5;269.0] | 225.0 [175.0;279.0] | < 0.001 |
Creatinie (mg/dL) | 0.8 [0.6; 0.9] | 1.0 [0.8; 1.4] | 0.8 [0.7; 1.0] | < 0.001 |
Lactate (mmol/L) | 2.6 [1.7; 4.0] | 5.6 [3.9; 7.9] | 3.0 [1.9; 5.0] | < 0.001 |
TB (mg/dL) | 0.8 [0.5; 1.1] | 1.1 [0.8; 1.7] | 0.8 [0.6; 1.2] | < 0.001 |
PT (sec) | 11.8 [10.9;12.9] | 13.1 [11.8;14.9] | 12.0 [11.0;13.3] | < 0.001 |